Coolidge Ave
Watertown, MA 02472
Due Diligence Pending
Equity Seeking$ 80,000,000
Equity StructurePreferred Equity
CRISPR Gene-Editing Biotech Seeking $80M Growth Capital for HIV, Hepatitis B & Herpes Cure Programs
Total Raise$ 80,000,000
Equity Seeking$ 80,000,000
Preferred Return10%
Profit Split (Investor/Sponsor)80 / 20
Project TypeBusiness Expansion
Hold Period3–5 Years
Entitlement StatusUnknown
Permit StatusNot Submitted
Loading...
Property Location
TTodd B.
Broker / Agent
Premium users get 3-day early access and can request up to 2 project packages per day.